Akero Therapeutics, Inc. (AKRO)
54.65
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
Akero Therapeutics EPS Diluted (Quarterly): -0.9946 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Eli Lilly & Co. | 6.211 |
| Bristol Myers Squibb Co. | 1.079 |
| Adaptive Biotechnologies Corp. | 0.0585 |
| Johnson & Johnson | 2.121 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -81.57M |
| Total Expenses (Quarterly) | 81.57M |
| Enterprise Value | 3.762B |
| Earnings Yield | -6.86% |
| Normalized Earnings Yield | -6.835 |